Financials
Financial year 2025
APOTHEEK VAN DER PLAETSEN from Evergem, company number BE0810650477, closed financial year 2025 with a result of € 191,402 after tax. For that financial year APOTHEEK VAN DER PLAETSEN recorded a gross margin of € 251,407 and equity of € 955,228. Compared with financial year 2024, the result moved from € 144,575 to € 191,402. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 29, 2026.
€ 955,228
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 191,402
▲ 32% vs 2024
Profit after tax over the fiscal year.
€ 192,060
▲ 43% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 85,000 paid out
44 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 510
▼ 97% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 114
▼ 87% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 16,829
Loans from banks and other lenders, long and short.
€ 55,191
▼ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,315
▲ 33% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 214,158 | € 236,840 | € 260,109 | € 251,407 | ▼ 3% |
| Profit after taxes | € 116,063 | € 131,950 | € 144,575 | € 191,402 | ▲ 32% |
| Equity | € 689,131 | € 745,752 | € 848,826 | € 955,228 | ▲ 13% |
| Total debts | € 155,149 | € 251,005 | € 261,523 | € 315,984 | ▲ 21% |
| Cash | € 334,834 | € 436,422 | € 134,690 | € 192,060 | ▲ 43% |
| Land & buildings | € 8,406 | € 6,305 | € 4,203 | € 2,102 | ▼ 50% |
| Retained profit | € 670,531 | € 727,152 | € 830,226 | € 936,628 | ▲ 13% |
| Dividend | € 72,450 | € 75,330 | € 41,500 | € 85,000 | ▲ 105% |
| Bank debt | € 9,726 | € 0 | € 16,900 | € 16,829 | |
| Balance sheet total | € 844,280 | € 996,756 | € 1,110,350 | € 1,271,213 | ▲ 14% |
| Employees (FTE) | - | 0.5 | 0 | 0 |
Key figures of APOTHEEK VAN DER PLAETSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK VAN DER PLAETSEN?
What happened at APOTHEEK VAN DER PLAETSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 191,402 (▲ 32% vs 2024). Source: NBB ↗
- New establishment in Evergem. KBO
- Start of the company according to the CBE. KBO
- Veronique Van Der Plaetsen became a director. NBB
In short
From € 116,063 profit in 2022 to € 191,402 profit in 2025.
Paid € 249,889 in corporate taxes since 2022.
Best year ever: 2025, with € 191,402 profit.
Paid out € 274,280 in dividends to the owners in total.
Management
Behind APOTHEEK VAN DER PLAETSEN is Veronique Van Der Plaetsen.
Directors
According to the 2025 annual accounts
Veronique Van Der Plaetsen
Director
since 2009
Establishments
Establishment units
Physical locations of this company
Elslo 180
9940 Evergem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0810.650.477
- VAT number
- BE 0810.650.477
- Registered office
- Elslo 180, 9940 Evergem
- Names & denominations
- APOTHEEK VAN DER PLAETSEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 March 2009
- Peppol
- Active · Active since 9 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten